D-1205-2018 Class III Terminated
FDA drug recall D-1205-2018 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Aug 27, 2018 and is designated Class III. Reason for recall: Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay. The recall status is terminated (terminated Oct 8, 2019). Affected quantity: 89,722 blister pack.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 26, 2018
- Initiation Date
- Aug 27, 2018
- Termination Date
- Oct 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89,722 blister pack
Product description
MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD NDC 59746-001-03
Reason for recall
Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.
Distribution pattern
Product was distributed throughout the United States.
Code information
Lot # 17P0078, exp. date 12/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1205-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026